ATM and cancer: While the majority of A-T patients (~90%) have truncating ATM mutations that result in little or no ATM protein expression (Concannon and Gatti, 1997), missense ATM mutations are more common in cancers and with the exception of the few that cause A-T, their biological functions are unknown.